Trastuzumab-Induced Cardiomyopathy and Intermittent Left Bundle Branch Block.
Cardiol Res
; 10(4): 230-235, 2019 Aug.
Article
in En
| MEDLINE
| ID: mdl-31413780
ABSTRACT
Trastuzumab-induced cardiomyopathy is a known complication of its use in breast cancer treatment, but it remains mostly asymptomatic and often reversible. Non-myopathic cardiac complications have been rarely reported with trastuzumab. These include left and right bundle branch block, arrhythmias and sinus node dysfunction. We report a case of a 52-year-old female breast cancer patient with trastuzumab-induced asymptomatic intermittent left bundle branch block recurring nearly a year after the initial diagnosis and resolution of trastuzumab-related cardiomyopathy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cardiol Res
Year:
2019
Document type:
Article
Affiliation country:
United States